Profile picture

Doctor Mashroor Khan

Karolinska Institute, Stockholm (Sweden)
Follow
Logo ESC

Contributor content

Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III
Journal
Population reach and participation rate in opportunistic vs. systematic atrial fibrillation screening: STROKESTOP III
30 August 2026
See more
Increasing the reach: optimizing screening for atrial fibrillation—the STROKESTOP III study
Journal
Increasing the reach: optimizing screening for atrial fibrillation—the STROKESTOP III study
20 September 2024
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources